Avila Therapeutics appoints first CEO
This article was originally published in Scrip
Executive Summary
Avila Therapeutics (US), an emerging biopharmaceutical company developing covalent drugs, has appointed Katrine Bosley chief executive officer. She joins from Adnexus, where she served as vice-president of business development and later as vice-president of strategic operations.